Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

97.49  +2.77 (+2.92%)

After market: 97.49 0 (0%)

Fundamental Rating

7

Overall CROX gets a fundamental rating of 7 out of 10. We evaluated CROX against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make CROX a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 19.74%, CROX belongs to the top of the industry, outperforming 91.84% of the companies in the same industry.
With an excellent Return On Equity value of 51.75%, CROX belongs to the best of the industry, outperforming 93.88% of the companies in the same industry.
CROX has a better Return On Invested Capital (23.23%) than 87.76% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 13.58%.
The last Return On Invested Capital (23.23%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROIC 23.23%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

Looking at the Profit Margin, with a value of 23.16%, CROX belongs to the top of the industry, outperforming 97.96% of the companies in the same industry.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX has a Operating Margin of 25.50%. This is amongst the best in the industry. CROX outperforms 97.96% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 58.76% is fine compared to the rest of the industry. CROX outperforms 73.47% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.74 indicates that CROX is not in any danger for bankruptcy at the moment.
The Altman-Z score of CROX (3.74) is better than 71.43% of its industry peers.
CROX has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.46, CROX belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
A Debt/Equity ratio of 0.74 indicates that CROX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, CROX is doing worse than 65.31% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Altman-Z 3.74
ROIC/WACC2.3
WACC10.1%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

CROX has a Current Ratio of 1.18. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.18, CROX is doing worse than 89.80% of the companies in the same industry.
CROX has a Quick Ratio of 1.18. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
CROX has a worse Quick ratio (0.70) than 85.71% of its industry peers.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.7
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.31%, which is quite good.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.53%.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%

3.2 Future

The Earnings Per Share is expected to grow by 3.74% on average over the next years.
The Revenue is expected to grow by 3.08% on average over the next years.
EPS Next Y0.91%
EPS Next 2Y2.8%
EPS Next 3Y1.39%
EPS Next 5Y3.74%
Revenue Next Year2.31%
Revenue Next 2Y2.85%
Revenue Next 3Y2.53%
Revenue Next 5Y3.08%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.41 indicates a rather cheap valuation of CROX.
Based on the Price/Earnings ratio, CROX is valued cheaper than 89.80% of the companies in the same industry.
When comparing the Price/Earnings ratio of CROX to the average of the S&P500 Index (28.22), we can say CROX is valued rather cheaply.
A Price/Forward Earnings ratio of 7.35 indicates a rather cheap valuation of CROX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 93.88% of the companies listed in the same industry.
CROX is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.41
Fwd PE 7.35
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than the industry average as 79.59% of the companies are valued more expensively.
83.67% of the companies in the same industry are more expensive than CROX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.92
EV/EBITDA 5.95
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)8.12
PEG (5Y)0.14
EPS Next 2Y2.8%
EPS Next 3Y1.39%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (5/2/2025, 8:00:01 PM)

After market: 97.49 0 (0%)

97.49

+2.77 (+2.92%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners100.85%
Inst Owner Change-0.04%
Ins Owners2.71%
Ins Owner Change5.14%
Market Cap5.47B
Analysts80.91
Price Target124.84 (28.05%)
Short Float %12.07%
Short Ratio3.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.58%
Min EPS beat(2)9.31%
Max EPS beat(2)13.84%
EPS beat(4)4
Avg EPS beat(4)16.59%
Min EPS beat(4)9.31%
Max EPS beat(4)32.88%
EPS beat(8)8
Avg EPS beat(8)14.13%
EPS beat(12)12
Avg EPS beat(12)15.66%
EPS beat(16)16
Avg EPS beat(16)20.22%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)4.37%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)7
Avg Revenue beat(12)0.76%
Revenue beat(16)10
Avg Revenue beat(16)1.73%
PT rev (1m)-5.31%
PT rev (3m)-7.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.85%
EPS NY rev (1m)-0.62%
EPS NY rev (3m)1.7%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 7.41
Fwd PE 7.35
P/S 1.33
P/FCF 5.92
P/OCF 5.51
P/B 2.98
P/tB N/A
EV/EBITDA 5.95
EPS(TTM)13.15
EY13.49%
EPS(NY)13.27
Fwd EY13.61%
FCF(TTM)16.47
FCFY16.89%
OCF(TTM)17.7
OCFY18.16%
SpS73.17
BVpS32.75
TBVpS-11.65
PEG (NY)8.12
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA 19.74%
ROE 51.75%
ROCE 25.69%
ROIC 23.23%
ROICexc 24.31%
ROICexgc 67.44%
OM 25.5%
PM (TTM) 23.16%
GM 58.76%
FCFM 22.5%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 1.46
Debt/EBITDA 1.21
Cap/Depr 99.29%
Cap/Sales 1.69%
Interest Coverage 10.52
Cash Conversion 88.95%
Profit Quality 97.17%
Current Ratio 1.18
Quick Ratio 0.7
Altman-Z 3.74
F-Score7
WACC10.1%
ROIC/WACC2.3
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.31%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-2.33%
EPS Next Y0.91%
EPS Next 2Y2.8%
EPS Next 3Y1.39%
EPS Next 5Y3.74%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.09%
Revenue Next Year2.31%
Revenue Next 2Y2.85%
Revenue Next 3Y2.53%
Revenue Next 5Y3.08%
EBIT growth 1Y-0.01%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year3.6%
EBIT Next 3Y2.04%
EBIT Next 5Y4.44%
FCF growth 1Y13.29%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y6.67%
OCF growth 3Y20.5%
OCF growth 5Y61.62%